Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis
Lysyl hydroxylase-2 (LH2) involves in the hydroxylation of telopeptide lysine residues during collagen deposition. Recent studies indicate that interleukin (IL)-6 generated by the chronic inflammation disease may trigger the LH2 expression to accelerate cell motility. Berberine is the alkaloid deriv...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.856777/full |
| _version_ | 1818274838743089152 |
|---|---|
| author | Yishan Du Muhammad Khan Nana Fang Fang Ma Hongzhi Du Zhenya Tan Hua Wang Shi Yin Shi Yin Xiaohui Wei |
| author_facet | Yishan Du Muhammad Khan Nana Fang Fang Ma Hongzhi Du Zhenya Tan Hua Wang Shi Yin Shi Yin Xiaohui Wei |
| author_sort | Yishan Du |
| collection | DOAJ |
| description | Lysyl hydroxylase-2 (LH2) involves in the hydroxylation of telopeptide lysine residues during collagen deposition. Recent studies indicate that interleukin (IL)-6 generated by the chronic inflammation disease may trigger the LH2 expression to accelerate cell motility. Berberine is the alkaloid derived from the traditional Chinese medicine Coptis chinensis, which displays potential anti-inflammatory activity in multiple diseases. The anti-inflammatory activity of berberine has been confirmed by reducing proinflammatory cytokines such as IL-6, IL-8, and IFN-γ. However, whether and how berberine inhibits cellular motility against metastatic spread in triple-negative breast cancer (TNBC) has not been demonstrated, and the underlying mechanism remains unclear. We investigated the effects of berberine on the inflammatory cytokine secretion, cell proliferation, and migration in vitro and further explored the effect of berberine on growth and metastasis in vivo. Berberine restrained TNBC cell proliferation, motility, and glycolysis process in a dose-dependent way. The secretion of IL-6 was abrogated by berberine in TNBC cells, and IL-6-stimulated cell migration was inhibited by berberine. Mechanistically, berberine remarkably suppressed LH2 expression at both mRNA and protein levels. LH2 depletion led to decreasing the antimotility effect of berberine, and this phenomenon was related to the suppressed glycolysis after LH2 inhibition. Conversely, ectopic restoration of LH2 could further increase the antimotility effect of berberine. Moreover, berberine was confirmed to inhibit cell growth and motility in vivo, and the expression of LH2 and glycolytic enzymes was also blocked by berberine in vivo. Collectively, this study indicated that berberine could be a promising therapeutic drug via regulating LH2 for TNBC. |
| first_indexed | 2024-12-12T22:20:13Z |
| format | Article |
| id | doaj.art-ea3a3c3d2097441b99b253f0e3395a8c |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-12-12T22:20:13Z |
| publishDate | 2022-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-ea3a3c3d2097441b99b253f0e3395a8c2022-12-22T00:09:56ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-04-011310.3389/fphar.2022.856777856777Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and GlycolysisYishan Du0Muhammad Khan1Nana Fang2Fang Ma3Hongzhi Du4Zhenya Tan5Hua Wang6Shi Yin7Shi Yin8Xiaohui Wei9Department of Geriatrics, Affiliated Provincial Hospital of Anhui Medical University, Anhui Medical University, Hefei, ChinaDepartment of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, ChinaDepartment of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, ChinaCenter for Scientific Research of Anhui Medical University, Hefei, ChinaSchool of Pharmacy, Hubei University of Chinese Medicine, Wuhan, ChinaDepartment of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, ChinaDepartment of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, ChinaDepartment of Geriatrics, Affiliated Provincial Hospital of Anhui Medical University, Anhui Medical University, Hefei, ChinaAnhui Provincial Key Laboratory of Tumor Immunotherapy and Nutrition Therapy, Hefei, ChinaDepartment of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, ChinaLysyl hydroxylase-2 (LH2) involves in the hydroxylation of telopeptide lysine residues during collagen deposition. Recent studies indicate that interleukin (IL)-6 generated by the chronic inflammation disease may trigger the LH2 expression to accelerate cell motility. Berberine is the alkaloid derived from the traditional Chinese medicine Coptis chinensis, which displays potential anti-inflammatory activity in multiple diseases. The anti-inflammatory activity of berberine has been confirmed by reducing proinflammatory cytokines such as IL-6, IL-8, and IFN-γ. However, whether and how berberine inhibits cellular motility against metastatic spread in triple-negative breast cancer (TNBC) has not been demonstrated, and the underlying mechanism remains unclear. We investigated the effects of berberine on the inflammatory cytokine secretion, cell proliferation, and migration in vitro and further explored the effect of berberine on growth and metastasis in vivo. Berberine restrained TNBC cell proliferation, motility, and glycolysis process in a dose-dependent way. The secretion of IL-6 was abrogated by berberine in TNBC cells, and IL-6-stimulated cell migration was inhibited by berberine. Mechanistically, berberine remarkably suppressed LH2 expression at both mRNA and protein levels. LH2 depletion led to decreasing the antimotility effect of berberine, and this phenomenon was related to the suppressed glycolysis after LH2 inhibition. Conversely, ectopic restoration of LH2 could further increase the antimotility effect of berberine. Moreover, berberine was confirmed to inhibit cell growth and motility in vivo, and the expression of LH2 and glycolytic enzymes was also blocked by berberine in vivo. Collectively, this study indicated that berberine could be a promising therapeutic drug via regulating LH2 for TNBC.https://www.frontiersin.org/articles/10.3389/fphar.2022.856777/fullberberineIL-6LH2motilityinflammation |
| spellingShingle | Yishan Du Muhammad Khan Nana Fang Fang Ma Hongzhi Du Zhenya Tan Hua Wang Shi Yin Shi Yin Xiaohui Wei Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis Frontiers in Pharmacology berberine IL-6 LH2 motility inflammation |
| title | Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis |
| title_full | Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis |
| title_fullStr | Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis |
| title_full_unstemmed | Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis |
| title_short | Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis |
| title_sort | berberine attenuates cell motility via inhibiting inflammation mediated lysyl hydroxylase 2 and glycolysis |
| topic | berberine IL-6 LH2 motility inflammation |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2022.856777/full |
| work_keys_str_mv | AT yishandu berberineattenuatescellmotilityviainhibitinginflammationmediatedlysylhydroxylase2andglycolysis AT muhammadkhan berberineattenuatescellmotilityviainhibitinginflammationmediatedlysylhydroxylase2andglycolysis AT nanafang berberineattenuatescellmotilityviainhibitinginflammationmediatedlysylhydroxylase2andglycolysis AT fangma berberineattenuatescellmotilityviainhibitinginflammationmediatedlysylhydroxylase2andglycolysis AT hongzhidu berberineattenuatescellmotilityviainhibitinginflammationmediatedlysylhydroxylase2andglycolysis AT zhenyatan berberineattenuatescellmotilityviainhibitinginflammationmediatedlysylhydroxylase2andglycolysis AT huawang berberineattenuatescellmotilityviainhibitinginflammationmediatedlysylhydroxylase2andglycolysis AT shiyin berberineattenuatescellmotilityviainhibitinginflammationmediatedlysylhydroxylase2andglycolysis AT shiyin berberineattenuatescellmotilityviainhibitinginflammationmediatedlysylhydroxylase2andglycolysis AT xiaohuiwei berberineattenuatescellmotilityviainhibitinginflammationmediatedlysylhydroxylase2andglycolysis |